MOTIVATION To make effective use of the vast amounts of expressed sequence tag (EST) sequence data generated by the Merck-sponsored EST project and other similar efforts, sequences must be organized into gene classes, and scientists must be able to 'mine' the gene class data in the context of related genomic data. RESULTS This paper presents the Merck Gene Index browser, an easily extensible,...

INTRODUCTION ................................................................................... 523 I. BACKGROUND ........................................................................... 525 A. Common Law Research Exception ......................................... 525 B. The Statutory Safe Harbor Provision: 271(e)(1) .................... 528 II. CASE LAW: THE SAFE HARBOR STATUE PROTECTION ...

Varivax (varicella virus vaccine live [Oka/Merck]; Merck), a live attenuated varicella vaccine, is indicated for vaccination against varicella in appropriate individuals > or =12 months of age. The 10-year safety profile for Varivax is described using data submitted to Merck from routine global postmarketing surveillance, combined with information from a Varicella Zoster Virus Identification Pr...

On October 21, 1987, Merck & Co., Inc., announced plans to donate Mectizan (ivermectin), a new medicine designed to combat onchocerciasis (Ôriver blindnessÕ), for as long as it might be needed. Merck took this action, working in col laboration with international experts in parasitology, the World Health Organization, and other agencies to reach those affected by the illness. This unusual decisi...

The Catalysis Laboratory at Merck was established in 2002 to discover and develop asymmetric hydrogenation transformations for application the company’s pipeline. Twenty years later, it is safe say that not only what now feels like modest goal accomplished, but many varied catalytic technologies have also emerged from this group. Furthermore, successes achieved locally spawned an array of furth...

G ardasil, the vaccine that protects women from common strains of the human papillomavirus (HPV) responsible for about 70% of cervical cancers, has proved successful. According to the Centers for Disease Control and Prevention’s National Immunization Survey, about 25% of women have received the vaccine. Now Merck, the pharmaceutical giant that manufactures Gardasil, is looking to match that suc...